Handelsbanken Fonder’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Handelsbanken Fonder’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,300	Closed	-$272K	–	1744
2021 Q1	$272K	Hold	2,300	–	–	﹤0.01%	1477
2020 Q4	$272K	Hold	2,300	–	–	﹤0.01%	1448
2020 Q3	$256K	Sell	2,300 -700	-23%	-$75.2K	﹤0.01%	1313
2020 Q2	$307K	Buy	+3,000	New	+$321K	﹤0.01%	1207

Handelsbanken Fonder's CBPO Position: Q2 2021 in Review

Handelsbanken Fonder sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 2,300 shares — an estimated $272K sold.

Handelsbanken Fonder first reported a position in CBPO in Q2 2020 and held it in 4 quarters. The position peaked at $307K in Q2 2020. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

Handelsbanken Fonder reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
Handelsbanken Fonder sold 2,300 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $272K.
Handelsbanken Fonder first reported a position in China Biologic Products Holdings, Inc. in Q2 2020 and held it in 4 quarters.
Handelsbanken Fonder's China Biologic Products Holdings, Inc. position peaked at $307K in Q2 2020.
0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on Handelsbanken Fonder's 13F filing for Q2 2021, filed 3 Aug 2021.